Dudediligence.

Canopy Growth Corporation

CGCNASDAQ · Medicinal Chemicals & Botanical Products
Write an idea

Price
FilingsNewest: 8-K, Auditor changeAug 7 →InsidersNo open-market buys. 7 insiders sold $265,470, 0 of 10 sales on a 10b5-1 plan.→Financing →PeersClosest companies: VFF, CRON, TLRY→

From the filings

Figures

Net income
−$189.0Mlast 12 months
Cash and equivalents
$364.7Mat the last balance sheet
Total debt
$233.4Mat the last balance sheet
Shares outstanding
423.0M shareson issue
Every year and quarter →